Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03448718
Title Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Matthew Galsky
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Chicago Medical Center Chicago Illinois 60637 United States Details
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore Maryland 21287 United States Details
Karmanos Cancer Center (Wyane State University) Detroit Michigan 48201 United States Details
Icahn School of Medicine at Mount Sinai New York New York 10029-6542 United States Details
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599 United States Details
Vanderbilt-Ingran Cancer Center Nashville Tennessee 37232 United States Details
Huntsman Cancer Institute University of Utah Salt Lake City Utah 84112-5550 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field